Evidence map›Paper›PMID 36458365›Full record

ArticleJournal of clinical laboratory analysis2023

Clinical value of long non-coding RNA KCNQ1OT1 in estimating the stenosis, lipid level, inflammation status, and prognostication in coronary heart disease patients.

Lin Zhu, Qiang Feng, Jie Fan, Jing Huang, Yanling Zhu, Yanqiang Wu, Aijun Hou, Yanfei Huo

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lin ZhuDepartment of Cardiology, HanDan Central Hospital, Handan, China.ORCID https://orcid.org/0000-0001-8521-2886
Qiang FengDepartment of Cardiology, HanDan Central Hospital, Handan, China.
Jie FanDepartment of Cardiology, HanDan Central Hospital, Handan, China.
Jing HuangGeriatrics Department, HanDan Central Hospital, Handan, China.
Yanling ZhuDepartment of Cardiology, HanDan Central Hospital, Handan, China.
Yanqiang WuDepartment of Cardiology, HanDan Central Hospital, Handan, China.
Aijun HouDepartment of Cardiology, HanDan Central Hospital, Handan, China.
Yanfei HuoPhysical Examination Center, HanDan Central Hospital, Handan, China.ORCID https://orcid.org/0000-0002-1954-8047
Handan College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLong non-coding RNA KQT-like subfamily, member 1 opposite strand/antisense transcript 1 (KCNQ1OT1) could regulate lipid metabolism, vascular smooth muscle cell function, inflammation, and atherosclerosis. This study aimed to evaluate whether lncRNA KCNQ1OT1 could serve as a biomarker for reflecting coronary heart disease (CHD) patients' disease situation and prognosis.

methodsLncRNA KCNQ1OT1 expression was determined in peripheral blood mononuclear cells from 267 CHD patients, 50 disease controls (DCs) (unexplained chest pain), and 50 healthy controls (HCs) by the RT-qPCR method. TNF-α, IL-17A, VCAM-1, and ICAM-1 were determined by the ELISA procedure in serum from CHD patients only. The mean (95% confidential interval) follow-up duration was 16.0 (15.3-16.8) months.

resultsLncRNA KCNQ1OT1 was highest in CHD patients, followed by DCs, and lowest in HCs (p < 0.001). LncRNA KCNQ1OT1 could distinguish the CHD patients from DCs (area under the curve [AUC]: 0.757) and from the HCs (AUC: 0.880). LncRNA KCNQ1OT1 was positively associated with triglyceride (p = 0.026), low-density lipoprotein cholesterol (p = 0.023), cardiac troponin I (p = 0.023), and C-reactive protein (p = 0.001). Besides, lncRNA KCNQ1OT1 was also positively linked with the Gensini score (p = 0.008). Furthermore, lncRNA KCNQ1OT1 was positively related to the TNF-α (p < 0.001), IL-17A (p = 0.008), and VCAM-1 (p = 0.003). LncRNA KCNQ1OT1 was elevated in CHD patients with MACE compared to those without MACE (p = 0.006); moreover, lncRNA KCNQ1OT1 high was associated with shorter MACE-free survival (p = 0.018).

conclusionCirculating lncRNA KCNQ1OT1 expression not only reflects the stenosis degree, blood lipid level, and inflammation status but also predicts the MACE risk, while a large-scale study is needed for verification.

Indexed as

Coronary DiseaseMicroRNAsRNA, Long NoncodingConstriction, PathologicHumansInflammationInterleukin-17Leukocytes, MononuclearLipidsTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1Interleukin-17LipidsMicroRNAsRNA, Long NoncodingTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1blood lipidcoronary heart diseaseinflammationLncRNA KCNQ1OT1major adverse cardiovascular event

Identifiers

PMID36458365
PMCPMC9833965
OpenAlexW4310592966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.